Preeclampsia-Related Hypertension: A Growing Concern in Iraq

Preeclampsia was a leading cause to perinatal along with maternal morbidity in the world, then our study focused specifically to study and analyze clinical results related to patients who suffer from preeclampsia-induced hypertension. We performed a cross-sectional study for 68 patients who have preeclampsia at different hospitals in Iraq from March 2024 to March 2025. Iraqi hospital patients' clinical data, including all disease features of diagnosis aspects, antihypertensive treatment, and maternal-fetal outcome, due to that, the current results found that predominantly nulliparous (60.3%) and obese (47.1%) women with severe features (63.2%), where the most prevalent comorbid conditions were chronic hypertension (22.1%) and gestational diabetes (17.6%). It also used antihypertensive was labetalol (66.2%), and 63.2% required magnesium sulfate for seizure prophylaxis. The most prevalent severe maternal complications were postpartum hemorrhage (11.8%) and ICU admission (10.3%), as well as the cesarean section rate was 67.6% in severe preeclampsia (52.2%), neonatal condition was critical at 51.5% low birth weight and 45.6% NICU admission. According to current results, our study indicated of testament to the preeclampsia's overburdening of preeclampsia and its association with excessive maternal complications. It compromised neonatal outcomes, which the extremely high prevalence of recurrent postpartum hypertension underscores the need for long-term follow-up in such patients to avert further negative health outcomes.